Vigil Neuroscience logo

Vigil Neuroscience

Cambridge, MA

Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

vigilneuro.com

Company Details

Founded

2020

Employees

Between 50 - 100 employees

Raised

$140,000,000

Headquarters Location

Cambridge, MA

Public

Yes

Acquired

No

CEO

Ivana Magovcevic-LiebischIvana Magovcevic-Liebisch

Company Collections

These are collections Vigil Neuroscience is a part of. Click on the collection name to view similar companies.

Vigil Neuroscience's Industries